
    
      100 patients will be randomized to receive Zerit (Stavudine) + Epivir (Lamivudine) + Crixivan
      (Indinavir) and 100 patients will be randomized to receive Retrovir (Zidovudine) + Epivir
      (Lamivudine) + Crixivan (Indinavir).

      Patients will be treated for 48 weeks.
    
  